HIF-2α-IN-2

CAS No. 1672666-82-8

HIF-2α-IN-2( —— )

Catalog No. M23751 CAS No. 1672666-82-8

HIF-2α-IN-2 is a hypoxia-inducible factor (HIF-2α) inhibitor (IC50: 16 nM in scintillation proximity assay).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 205 In Stock
10MG 282 In Stock
25MG 489 In Stock
50MG 705 In Stock
100MG 981 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    HIF-2α-IN-2
  • Note
    Research use only, not for human use.
  • Brief Description
    HIF-2α-IN-2 is a hypoxia-inducible factor (HIF-2α) inhibitor (IC50: 16 nM in scintillation proximity assay).
  • Description
    HIF-2α-IN-2 is a hypoxia-inducible factor (HIF-2α) inhibitor (IC50: 16 nM in scintillation proximity assay).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    HIF/HIF Prolyl-hydroxylase
  • Recptor
    HIF-2α
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1672666-82-8
  • Formula Weight
    365.35
  • Molecular Formula
    C17H13F2NO4S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:100 mg/mL (273.71 mM; Need ultrasonic)
  • SMILES
    N#CC1=CC(OC2=CC=C(S(=O)(C)=O)C3=C2CC(F)C3O)=CC(F)=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Darryl David DIXON, et al. Aryl ethers and uses thereof. WO2015035223A1.
molnova catalog
related products
  • BAY 87-2243

    BAY 87-2243 is a potent and selective hypoxia-inducible factor-1 (HIF-1) inhibitor. Phase 1.

  • QX77

    QX77 is a chaperone-mediated autophagy (CMA) activator.

  • Naphthofluorescein

    Naphthofluorescein (Naphthafluorescein) is a Mint3 inhibitor with potential antitumor and anti-inflammatory activities, inhibits the interaction between HIF-1 and Mint3, inhibits Mint3-dependent HIF-1 activity, and inhibits glycolytic activity in cancer cells and macrophages without showing significant in vitro cytotoxicity or in vivo side effects.